Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-920-2013

Drug recall · September 4, 2013

Magnesium Sulfate Injection recall

Why: Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50

Lots / codes

Lot #: 6103882, Exp 10/14

Quantity
15,625 vials
Company
Fresenius Kabi USA, LLC, Lake Zurich, IL
Distribution
Nationwide
Initiated
May 25, 2013 · Voluntary: Firm initiated
Classified
August 23, 2013
Reported
September 4, 2013
Ended
March 10, 2016
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Magnesium sulfate

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.